Actuate Therapeutics, Inc. Common stock (NASDAQ: ACTU) last traded at $0.466, down 27.56% on the session. The quote above updates while this page is open; the figures below are drawn from Actuate Therapeutics, Inc. Common stock’s own filings and are restated only when a new one is published.
Actuate Therapeutics, Inc. Common stock trades on NASDAQ under the ticker ACTU. Its market capitalisation is $11.20 million.
Valuation measures for Actuate Therapeutics, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $11.20M |
|---|---|
| Enterprise value | $10.98M |
| Price / book | 11.32 |
| Beta | 1.71 |
Trailing-twelve-month figures tagged in Actuate Therapeutics, Inc. Common stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$20.45M |
| EPS (TTM) | -$0.880 |
|---|
| Return on equity | -2067.81% |
|---|
| Cash | $4.43M |
|---|
Range and volume for ACTU over the past 52 weeks.
| 52-week high | $8.20 |
|---|---|
| 52-week low | $0.438 |
| Volume | 962.8K |
| Average volume | 359.1K |
| Previous close | $0.644 |
Invest a chosen dollar amount in Actuate Therapeutics, Inc. Common stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ACTU.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.